FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093015584> ?p ?o ?g. }

• W3093015584 endingPage "556" @default.
• W3093015584 startingPage "549" @default.
• W3093015584 abstract "Objectives Although feline mammary carcinomas (FMCs) are highly metastatic, the literature and treatment options pertaining to advanced tumours are scarce. This study aimed to investigate the clinical outcome of metastatic FMC with or without adjuvant treatment. Methods The medical records of 73 cats with metastatic FMC (stage IV) were reviewed and included in this study. Metastatic disease was detected by distinct imaging techniques (radiography, ultrasound and CT) and confirmed by cytology and/or histopathology. Cats with adjuvant chemotherapy treatment (n = 34) were divided into three groups: group 1 (n = 9) cats receiving maximum tolerated dose chemotherapy; group 2 (n = 15) cats receiving metronomic chemotherapy; and group 3 (n = 10) cats treated with toceranib phosphate. The study endpoints were time to progression (TTP) and tumour-specific survival (TSS). Treatment-related toxicity was evaluated according to the Veterinary Co-operative Oncology Group’s Common Terminology Criteria for Adverse Events version 1.1 (VCOG-CTCAE). Results Overall mean TTP and TSS were 23 and 44 days, respectively. Cats with clinical signs at the time of diagnosis had a lower TSS (14 days) than asymptomatic cats (128 days; P <0.001). Cats with pleural effusion had a lower TSS (16 days) than cats without ( P <0.001). Median TSS was 58, 75 and 63 days in groups 1, 2 and 3, respectively ( P = 0.197). Toxicity was observed in 66.7%, 20% and 30% of cats in groups 1, 2 and 3, respectively. Conclusions and relevance To the best of our knowledge, this study includes the highest number of patients with metastatic FMC assessed. Despite the overall poor prognosis, some cats survived >6 months, indicating that adjuvant treatment may be an option to consider in metastatic disease. More studies are warranted for better understanding and management of stage IV patients." @default.
• W3093015584 created "2020-10-22" @default.
• W3093015584 creator A5007539486 @default.
• W3093015584 creator A5022630477 @default.
• W3093015584 creator A5023255171 @default.
• W3093015584 creator A5024483891 @default.
• W3093015584 creator A5025795157 @default.
• W3093015584 creator A5053814425 @default.
• W3093015584 creator A5055204944 @default.
• W3093015584 creator A5056706330 @default.
• W3093015584 creator A5088120224 @default.
• W3093015584 date "2020-10-20" @default.
• W3093015584 modified "2023-10-17" @default.
• W3093015584 title "Metastatic feline mammary cancer: prognostic factors, outcome and comparison of different treatment modalities – a retrospective multicentre study" @default.
• W3093015584 cites W1485575863 @default.
• W3093015584 cites W1984025827 @default.
• W3093015584 cites W1992366684 @default.
• W3093015584 cites W2002757479 @default.
• W3093015584 cites W2021460099 @default.
• W3093015584 cites W2024331903 @default.
• W3093015584 cites W2030140264 @default.
• W3093015584 cites W2037303129 @default.
• W3093015584 cites W2048229425 @default.
• W3093015584 cites W2066588750 @default.
• W3093015584 cites W2067259499 @default.
• W3093015584 cites W2083530801 @default.
• W3093015584 cites W2093312780 @default.
• W3093015584 cites W2099782905 @default.
• W3093015584 cites W2104298035 @default.
• W3093015584 cites W2107313238 @default.
• W3093015584 cites W2118303647 @default.
• W3093015584 cites W2119032282 @default.
• W3093015584 cites W2133982242 @default.
• W3093015584 cites W2141815918 @default.
• W3093015584 cites W2235688937 @default.
• W3093015584 cites W2289192053 @default.
• W3093015584 cites W2319772961 @default.
• W3093015584 cites W2347059510 @default.
• W3093015584 cites W2402915576 @default.
• W3093015584 cites W2412409674 @default.
• W3093015584 cites W2515030597 @default.
• W3093015584 cites W2594281381 @default.
• W3093015584 cites W2603672149 @default.
• W3093015584 cites W2773850487 @default.
• W3093015584 cites W2792778928 @default.
• W3093015584 cites W2807825151 @default.
• W3093015584 cites W2954509455 @default.
• W3093015584 cites W3005643552 @default.
• W3093015584 cites W3007215200 @default.
• W3093015584 cites W4237653769 @default.
• W3093015584 cites W4239051461 @default.
• W3093015584 cites W4249710322 @default.
• W3093015584 doi "https://doi.org/10.1177/1098612x20964416" @default.
• W3093015584 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33078692" @default.
• W3093015584 hasPublicationYear "2020" @default.
• W3093015584 type Work @default.
• W3093015584 sameAs 3093015584 @default.
• W3093015584 citedByCount "11" @default.
• W3093015584 countsByYear W30930155842021 @default.
• W3093015584 countsByYear W30930155842022 @default.
• W3093015584 countsByYear W30930155842023 @default.
• W3093015584 crossrefType "journal-article" @default.
• W3093015584 hasAuthorship W3093015584A5007539486 @default.
• W3093015584 hasAuthorship W3093015584A5022630477 @default.
• W3093015584 hasAuthorship W3093015584A5023255171 @default.
• W3093015584 hasAuthorship W3093015584A5024483891 @default.
• W3093015584 hasAuthorship W3093015584A5025795157 @default.
• W3093015584 hasAuthorship W3093015584A5053814425 @default.
• W3093015584 hasAuthorship W3093015584A5055204944 @default.
• W3093015584 hasAuthorship W3093015584A5056706330 @default.
• W3093015584 hasAuthorship W3093015584A5088120224 @default.
• W3093015584 hasConcept C121608353 @default.
• W3093015584 hasConcept C126322002 @default.
• W3093015584 hasConcept C142724271 @default.
• W3093015584 hasConcept C167135981 @default.
• W3093015584 hasConcept C18823058 @default.
• W3093015584 hasConcept C197934379 @default.
• W3093015584 hasConcept C2776694085 @default.
• W3093015584 hasConcept C2777793932 @default.
• W3093015584 hasConcept C2777910003 @default.
• W3093015584 hasConcept C2779904517 @default.
• W3093015584 hasConcept C544855455 @default.
• W3093015584 hasConcept C71924100 @default.
• W3093015584 hasConcept C90924648 @default.
• W3093015584 hasConceptScore W3093015584C121608353 @default.
• W3093015584 hasConceptScore W3093015584C126322002 @default.
• W3093015584 hasConceptScore W3093015584C142724271 @default.
• W3093015584 hasConceptScore W3093015584C167135981 @default.
• W3093015584 hasConceptScore W3093015584C18823058 @default.
• W3093015584 hasConceptScore W3093015584C197934379 @default.
• W3093015584 hasConceptScore W3093015584C2776694085 @default.
• W3093015584 hasConceptScore W3093015584C2777793932 @default.
• W3093015584 hasConceptScore W3093015584C2777910003 @default.
• W3093015584 hasConceptScore W3093015584C2779904517 @default.
• W3093015584 hasConceptScore W3093015584C544855455 @default.
• W3093015584 hasConceptScore W3093015584C71924100 @default.
• W3093015584 hasConceptScore W3093015584C90924648 @default.
• W3093015584 hasFunder F4320334779 @default.

• next